04 March 2026
Can the brain sense cancer? Up to $25M awarded to a team including the Champalimaud Foundation to explore a new frontier in oncology
Led by the Francis Crick Institute in the UK, the team brings together clinicians, scientists and patient advocates, with researchers spanning eight institutions across four countries. The award is funded jointly by Cancer Research UK and the National Cancer Institute in the US, two of the world’s largest cancer research funders, through the global Cancer Grand Challenges initiative. It marks the first time this prestigious international award has been granted to a Portuguese institution.
26 February 2026
Champalimaud Foundation and Instituto Superior Técnico Join Forces to Lead Research in Neurorobotics
The Champalimaud Foundation (CF) and Instituto Superior Técnico (IST) have established a five-year strategic partnership to create a Neurorobotics Laboratory within the CF Neurotechnology Warehouse. Signed on 18 February, the agreement brings together two of Portugal’s leading research institutions with the goal of advancing the understanding of intelligence - both biological and artificial - at the convergence of brain science, robotics and artificial intelligence.
Medica AI 2026
Healthcare is entering a decisive decade.
Artificial Intelligence (AI) is no longer a promise on the horizon – it is already transforming diagnostics, treatment, research, education and health systems worldwide. The real challenge we now face is not whether AI will change healthcare, but how we design that transformation responsibly, sustainably and at scale.
PATEO – Pessoas com Autonomia, Tecto, Espaço e Oportunidade
Date and Time
27 March 2026, 2:30pm – 6:30pm
Location
Auditorium, Champalimaud Foundation, Lisbon
About
PATEO is a Science4Policy project that translates scientific evidence on the prevention of dementia and age-related functional decline into concrete, actionable solutions to support healthier aging, greater autonomy and improved quality of life.
